FALASCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.955
EU - Europa 156
AS - Asia 119
SA - Sud America 2
Totale 2.232
Nazione #
US - Stati Uniti d'America 1.954
SG - Singapore 88
DE - Germania 27
IE - Irlanda 26
CN - Cina 23
IT - Italia 22
RU - Federazione Russa 20
UA - Ucraina 17
FR - Francia 13
CZ - Repubblica Ceca 8
GB - Regno Unito 7
PL - Polonia 6
FI - Finlandia 5
JP - Giappone 3
BE - Belgio 2
DK - Danimarca 2
KR - Corea 2
BR - Brasile 1
CA - Canada 1
CL - Cile 1
IN - India 1
LK - Sri Lanka 1
SE - Svezia 1
TW - Taiwan 1
Totale 2.232
Città #
Wilmington 609
Houston 506
Woodbridge 365
Singapore 84
Fairfield 76
Chandler 61
Ashburn 38
Ann Arbor 35
Cambridge 27
Seattle 25
Dublin 21
Santa Clara 21
Medford 17
Dearborn 13
Rome 13
Beijing 12
Jacksonville 11
Brno 8
Lawrence 8
New York 8
Munich 6
San Diego 6
Kraków 5
Kunming 5
Menlo Park 5
Moscow 5
Engelhard 4
Palo Alto 3
Brussels 2
Creede 2
Hefei 2
La Veta 2
Osaka 2
Saint Petersburg 2
St. George 2
Atlanta 1
Chengdu 1
Chiswick 1
Colombo 1
Helsinki 1
Hounslow 1
Kaohsiung 1
Lappeenranta 1
Melegnano 1
Mountain View 1
Nanjing 1
North Hollywood 1
Novokuznetsk 1
Osasco 1
Pisa 1
Pune 1
Shanghai 1
Toronto 1
University Park 1
Warsaw 1
Washington 1
Totale 2.032
Nome #
Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions. 395
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells 387
Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication 377
TG2 regulates the heat-shock response by the post-translational modification of HSF1. 317
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection 302
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2. 267
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis 55
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois 40
ZFP750 affects the cutaneous barrier through regulating lipid metabolism 30
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants 25
Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for covid-19 therapy 24
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma 22
Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis 18
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection 16
Totale 2.275
Categoria #
all - tutte 5.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 0 0 0 63 53 69 56 55 69 46 48 46
2020/2021379 49 45 43 40 37 43 41 50 11 7 11 2
2021/202286 8 6 0 3 1 10 8 10 3 5 11 21
2022/2023139 10 18 1 19 20 21 13 9 15 0 3 10
2023/202496 13 5 5 3 10 15 0 1 10 12 2 20
2024/2025161 6 100 49 6 0 0 0 0 0 0 0 0
Totale 2.275